Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Genentech, Inc.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
(Applicable to healthy subjects only) Healthy subjects not taking any regular prescription medication, without history of allergy, and considered healthy by the physician
(Applicable to asthma patients only) Patients with atopic asthma diagnosed by a physician with asthma and history of positive skin test(s)
Physical examination findings within normal limits
Body mass index (BMI) between 18 and 30, inclusive
You may not be if
Pregnancy and lactation
Current or previous treatment with a biologic agent (e.g., monoclonal antibody)
Concurrent disease or condition that would interfere, or for which the treatment might interfere with the conduct of the study, or that would, in the opinion of the investigator, pose an unacceptable risk to individuals in this study
History or symptoms of significant psychiatric disease, including but not limited to, depression, schizophrenia, etc.
History of drug abuse
Participation in an investigational drug or device trial within the last 30 days prior to screening
Clareo Health | The Safety and Utility of Skin Testing With XOLAIR® (Omalizumab) and Placebo Omalizumab (Formulation Excipients)
